RCS - GenIP PLC - Strategic Partnership

GenipAnnouncement

24/09/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250924:nRSX4851Aa&default-theme=true

RNS Number : 4851A  GenIP PLC  24 September 2025

 

24 September 2025

 

GenIP Plc

("GenIP" or the "Company")

 

Strategic Corporate Partnership with 360 Social Impact Studios

 

GenIP Plc, a technology consultancy providing Generative Artificial
Intelligence (GenAI) services to help organisations commercialise their
innovations, is pleased to announce a strategic corporate partnership with 360
Social Impact Studios ("360"), a global innovation consulting firm and venture
studio based in Seatle. This partnership marks a significant step in GenIP's
expansion into the corporate market.

The collaboration will embed GenIP's Invention Evaluator reports into 360's
innovation platform, making it the standardised first step in their
venture-building methodology. This will ensure every 360's project undergoes a
rigorous assessment for market potential and commercial readiness before
moving forward.

Through this partnership GenIP's role transforms from being an external
service provider into becoming a core component of 360's platform, securing a
predictable, recurring revenue stream. It also gives GenIP direct access to a
pipeline of 50+ active engagements and new ventures, and over 100 corporate
clients, expanding its market presence beyond its traditional academic base.

The partnership also creates significant cross-selling opportunities for
GenIP's recruitment and leadership hiring services as 360's portfolio
companies scale and build their teams.

Melissa Cruz, CEO of GenIP, commented:

"This corporate strategic partnership represents a significant milestone for
GenIP. By embedding our Invention Evaluator into 360's global framework, we
transition from being a project-based service to a foundational part of their
innovation infrastructure. This provides GenIP with predictable revenue and
direct access to a broad corporate pipeline, reinforcing our strategy to grow
our presence in the corporate sector."

Chandler Lewis, Managing Director and Founder of 360 Social Impact Studios,
commented:

"Integration of GenIP's services addresses two critical gaps we see in
early-stage innovation: rigorous validation and strategic talent acquisition.
Their Invention Evaluator ensures we are not just advancing interesting ideas,
but viable ones with clear paths to market. Further, their talent platform
helps ventures build teams that bring both expertise and lived experience. For
our global network of clients and partners, this means better investment
decisions and stronger ventures. For the communities we serve, it means
innovations that actually work for them."

About 360 Social Impact Studios

360 Social Impact Studios builds and scales tech-enabled ventures that deliver
measurable social, environmental and financial outcomes. Its three-pillar
approach combines:

●    Innovation Program Design - ISO 56002-aligned frameworks guiding
institutions from ideation to implementation.

●    Direct Venture Building - hands-on co-creation with founders in
healthcare, sustainability, education and beyond.

●    Leadership Transformation - equipping organisations with the mindset
and culture to embed innovation at scale.

Recent work includes AI-enabled diagnostics, next-generation rehabilitation
platforms, and licensing systems-areas where robust IP and market assessments
are critical for investor confidence.

 

 

 

 

For further information regarding GenIP, please visit www.genip.ai
(http://www.genip.ai/) , or contact:

 

 GenIP Plc                                                          Via Redchurch Communications

 Melissa Cruz, CEO

 Novum Securities Limited (Broker)                                  Tel: +44 (0)20 7399 9425

 Jon Belliss                                                        JBelliss@novumsecurities.com

 Redchurch Communications (Financial PR)                            genip@weareredchurch.com (mailto:genip@weareredchurch.com)

 John Casey

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on Reach.

 

Notes to Editors

 

About GenIP

 

GenIP provides generative artificial intelligence (GenAI) analytic services to
help companies, research institutions and venture funds assess and
commercialise new discoveries. GenIP combines expert human technical review
with GenAI algorithms to provide insightful and verified services.

 

GenIP provides two complementary services:

 

1.   Invention Evaluator: Provides bespoke research reports that assess the
market potential of new technological innovations and discoveries using
AI-driven proprietary software; and

 

2.   Vortechs: which is an executive recruitment service that uses advanced
machine learning algorithms and natural language processing technologies to
assist in matching technology organisations with experienced executives
skilled in technology commercialisation.

 

The Company believes that its integrated GenAI service offerings will help
organisations to evaluate and commercialise their technological innovations.

 

Company Strategy

 

GenIP's goal is to be a leading Generative AI analytic services company. To
achieve this, the Company has established three strategic pillars:

 

●    Organically grow Invention Evaluator and Vortechs' revenue through
institutional and corporate connections as well as increase client pipeline
through marketing, advertising and social media spend.

●    Expand the Generative AI service offerings within Invention
Evaluator and Vortechs' to reach new customers and improve margins.

●    Bolt-on acquisitions of additional Generative AI services that are
helpful to our clients and have demonstrated initial market traction.

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking
statements. When used in this announcement, the words "may", "would", "could",
"will", "intend", "plan", "anticipate", "believe", "seek", "propose",
"estimate", "expect", and similar expressions, as they relate to the Company,
are intended to identify forward-looking statements. These statements include,
but are not limited to, statements regarding intentions, beliefs or current
expectations concerning, among other things, the Company's results of
operations, financial position, liquidity, prospects, growth, strategies and
expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future
events and are subject to certain risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or achievements
to materially differ from those described in this announcement Should one or
more of these risks or uncertainties materialise, or should assumptions
underlying forward-looking statements prove incorrect, actual results may
differ materially from those described in this announcement as "intended",
"planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any
hyperlinks accessible from the Company's website are not incorporated by
reference into, and do not form part of, this announcement and investors
should not rely on them.

-ENDS-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRALJMBTMTATBJA